RE:"Long and Strong" or "Bagholder" - ???w8asec wrote:
That's the real question here... What's the difference? - The answer is TIME. All Bagholders feel Long & Strong at some point.
Many shareholders of Nortel road it up over $100 and back to zero having never sold a share.
BTW - When you read between the lines of the P.R.'s you get the feeling the Science is CR@P, so I think you have bad science and great management here.... You have to be pretty good managers to sell this story for sooooo long.
Hey guys, cut w8asec some slack, he’s just another disillusioned and disappointed Telesta bagholder/holdover who didn’t bother to read the trial data PR results or the FDA’s minimum 40% requirement for Telesta’s drug approval, if he had done some due diligence he would have read Telesta only achieved a 18% trial success rate (according to the FDA) when the FDA said they required a minimum 40% trial success rate for approval. I guess I f w8asec actually knew what he was talking about he would have sold at least half his Telesta holdings prior to the Telesta FDA debacle like most of us did who actually took the time to read all the data and the FDA requirements for approval.
Comparing the science of a past bagholder like Telesta to Prometic’s science means their’s something lacking in reading comprehension, your math doesn’t work: 18% trial success rate vs. 100% trial success rate for Ryplazim is a bit of a difference, eh?
It’s always good to know what you’re talking about in terms of scientific data and verifiable trial results when investing in biotech; and from the looks of w8asec’s post it appears he has not finished his homework assignment... maybe the dog ate his homework, eh?
Nice try on the FUD side though w8asec, I’ll give you that...
Prometic might turn out better for you than Telesta did, hopefully...
FACTS:
4050 reverses fibrosis in five organs, no drug can make that claim
4050 works in Alstrom patients, no drug can make that claim
Ryplazim will own the entire plasminogen market ($8+ Billion USD)
gl2u w8asec